Malaysia Market Research
Malaysia
Market Overview: Malaysia has been recognized for its excellence in the Islamic economy, having ranked first in the world for nine consecutive years in the Global Islamic Economy Indicator. Malaysia’s success in the halal pharmaceutical space is part of its broader success in the Islamic economy, which includes halal food, finance, and lifestyle sectors.
Regulations: Although Halal certification in Malaysia is still voluntary, the country is a pioneer in establishing halal certification standards for pharmaceutical items and is committed to establishing a comprehensive halal ecosystem by 2030.
Market Size: Malaysia has a population of 34 million of which 61% are Muslim.
Market Potential: The Malaysian Halal pharmaceuticals market was valued at US $3.8 billion in 2018, rose to US $4.0 billion in 2021, and is expected to grow to US $4.8 billion by 2025.
Learn more
Market Activity: Malaysian halal pharma exports dropped by 24% in 2020 due to COVID-19. However, there was a 1.25% increase in investment in halal pharmaceutical production parks. Halal Park is a community of manufacturing and service businesses located on common property to preserve the integrity of Halal products.
Important Activities in the Malaysian Halal Pharmaceutical Market:
Malaysia Set to Help Others Build Halal Ecosystem
Malaysia is ready to assist and collaborate with other countries to build a robust halal ecosystem and collectively tap into this economic opportunity.
Duopharma Biotech Sees Promising Collaboration Opportunities in Qatar
Duopharma Biotech foresees collaboration opportunities in Qatar to advance Halal pharmaceuticals, emphasizing global integration and healthcare enhancement.
HDC Malaysia Calls for Expansion of its Halal Pharmaceutical into MENA Region
The CEO of HDC noted that by collaborating with the Islamic Development Bank, Malaysia could boost its halal pharmaceutical output to US$5.9 billion by 2030 and successfully enter the Middle Eastern market.
Halal Horizons: Future of Pharmaceutical Science at Taylor’s University
Taylor’s University’s programme teaches students to uphold halal practices in the cosmetic industry, preparing them for the expanding halal pharmaceutical sector.
Duopharma Biotech: A Beacon of Innovation in Malaysia’s Healthcare Landscape, Celebrated by Frost & Sullivan
Duopharma Biotech Berhad, a pioneer in halal pharmaceuticals, was named the 2022 Malaysian Company of the Year. They’ve made strides in biosimilars, notably with ERYSAA® for anemia in kidney disease. With high customer satisfaction and a diverse portfolio, they’re setting industry standards.
Rising to Global Prominence: The Evolution and Impact of Malaysia’s Halal Pharmaceutical Industry
Under the guidance of Jakim and NPRA, Malaysia’s halal pharmaceutical industry has seen significant growth. Despite challenges in global expansion, it continues to innovate and thrive. Backed by key players and government initiatives, it positions itself as a leader in high-quality halal medicines.
Halal Development Corporation Berhad, SOLV Malaysia Unite to Help Medium-sized Enterprises Access RM2.67 Billion Halal Fund
This collaboration simplifies financing processes and promotes SMEs’ growth and sustainability.
Malaysia is a Paragon of a Thriving Halal Industry. Here’s Why.
Malaysia has topped the world in the Global Islamic Economy Indicator (GIEI), according to DinarStandard’s State of the Global Islamic Economy Report 2022.
In conversation with Hairol Ariffein Sahari, CEO – Halal Development Corporation
Salaam Gateway interviews Hairol Ariffein Sahari, chief executive officer of Halal Development Corporation, Malaysia’s government-backed agency, mandated to develop the country’s integrated halal ecosystem.
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market
The worldwide pioneer in the research and development of halal pharmaceuticals is expanding and improving its Halal portfolio to differentiate itself from competitors.
Duopharma to Expand Portfolio Diversity Including Halal Pharmaceuticals
Duopharma Biotech Bhd has reaffirmed its commitment to expanding its portfolio diversity, including halal pharmaceuticals and plant-based products, and growing its product availability and affordability.
Malaysia Invites Mindanao to International Halal Showcase
Malaysia and the Philippines are looking further into developing halal trade investment portfolios, especially in Mindanao.
Duopharma is First in Malaysia to Receive Halal Certification for Oncology Product
In December 2022, Duopharma Biotech Bhd made history by becoming the first pharmaceutical company to receive halal certification for an oncology product.
Pharmaniaga’s World First Halal Vaccine and Insulin Plants Construction Nearing 90% Completion
Pharmaniaga Berhad, is working towards building the world’s first Halal vaccine and insulin plants.
Duopharma to Distribute Halal Anti-Hair Loss Products
Duopharma distribute a range of halal-certified anti-hair loss products under the Iroro brand in Malaysia.
Pharmaniaga, and Ronnsi Pharma Partnership to Commercialize Malaysia’s First Halal Blood Anti-coagulant
Pharmaniaga Berhad, a leading pharmaceutical group in Malaysia, has partnered with China’s Suzhou Ronnsi Pharma Co., Ltd. to distribute a halal ovine (sheep) anticoagulant in Malaysia.
Duopharma Expands its Halal Nutraceuticals
Duopharma is entering a joint venture with Bangladeshi pharma players to develop halal-certified medicines.
Duopharma Biotech Sets out to Expand Health and Beauty Range
Launch of Flavettes Effervescent Glamz – Duopharma Biotech Berhad to Launch of Flavettes Effervescent Glamz.
AstraZeneca And Sunway Launch Malaysia’s First Health Innovation Hub
the hub aimes at improving the treatment of non-communicable diseases.
Malaysia’s Pharmaniaga to make pneumococcal vaccine, will seek JAKIM halal certification
Pharmaniaga’s subsidiary, Pharmaniaga Lifescience (PLS), will market, distribute and sell the product exclusively in Malaysia, and it will be halal certified by JAKIM.
Duopharma, Introduces Its Second Oncology Drug to Treat Chronic Myeloid Leukemia
The new anti-cancer drug is a significant addition to the company’s growing portfolio of halal-certified pharmaceutical products..
World’s First Halal Biosimilar to Be Produced in Malaysia
Malaysia’s VentureTECH, Duopharma Biotech Bhd, and PanGen
Biotech from South Korea join hands to establish a commercial biosimilar production center in Malaysia.
